Pancreatic Cancer Research

ResearcherMayo ClinicNo recent work listed

Chen Jiang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4672-3549; OpenAlex author ID A5101819927. Sources: OpenAlex.

Their work

Papers
8 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
32
Papers, trials and grants by year

2012: 2 papers · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper

Papers 8

  1. Metabolomic Detection Between Pancreatic Cancer and Liver Metastasis Nude Mouse Models Constructed by Using the PANC1-KAI1/CD82 Cell Line. First author DOI 10.1177/15330338211045204↗
  2. An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance). First author DOI 10.1097/fpc.0000000000000375↗
  3. The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation. Co-author DOI 10.1371/journal.pone.0202272↗
  4. Clinical Outcomes of Specific Immunotherapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis. Co-author DOI 10.1155/2017/8282391↗
  5. Pancreatic cancer: diagnosis and treatments. Co-author DOI 10.1007/s13277-015-3223-7↗
  6. 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). Co-author DOI 10.1093/jnci/dju185↗
  7. Identification of potential prognostic biomarkers in patients with untreated, advanced pancreatic cancer from a phase 3 trial (Cancer and Leukemia Group B 8030… Co-author DOI 10.1002/cncr.26270↗
  8. A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303. Co-author DOI 10.1158/1078-0432.ccr-11-1387↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kouros Owzar · 5 shared papers, 2012–2019 · strength 0.23
  2. Hedy Lee Kindler · 5 shared papers, 2012–2019 · strength 0.23
  3. Hongyu Li · 2 shared papers, 2015–2021 · strength 0.22
  4. Federico Innocenti · 4 shared papers, 2012–2019 · strength 0.20
  5. Mark J. Ratain · 3 shared papers, 2012–2019 · strength 0.16
  6. Shuo Wang · 1 shared paper, 2021 · strength 0.16
  7. Xiaozhong Guo · 1 shared paper, 2021 · strength 0.16
  8. Xingshun Qi · 1 shared paper, 2021 · strength 0.16
  9. Xu Liu · 1 shared paper, 2021 · strength 0.16
  10. Alan Paul Venook · 3 shared papers, 2012–2018 · strength 0.13
  11. Xingshun Qi · 1 shared paper, 2017 · strength 0.12
  12. Herbert I. Hurwitz · 2 shared papers, 2012–2019 · strength 0.10
  13. Katherine Van Loon · 2 shared papers, 2014–2018 · strength 0.10
  14. Yusuke Nakamura · 2 shared papers, 2012–2018 · strength 0.08
  15. Andrew B. Nixon · 1 shared paper, 2019 · strength 0.08
  16. Eileen Mary O'Reilly · 2 shared papers, 2012–2014 · strength 0.07
  17. Yingyi Li · 1 shared paper, 2015 · strength 0.06
  18. Xiaozhong Guo · 1 shared paper, 2015 · strength 0.06
  19. Nicole F. Neel · 1 shared paper, 2018 · strength 0.06
  20. Marina Talamonti · 1 shared paper, 2018 · strength 0.06
  21. David J. Bentrem · 1 shared paper, 2018 · strength 0.06
  22. Jen Jen Yeh · 1 shared paper, 2018 · strength 0.06
  23. Gloria M. Petersen · 1 shared paper, 2018 · strength 0.06
  24. Robert R. McWilliams · 1 shared paper, 2018 · strength 0.06
  25. Richard M. Goldberg · 2 shared papers, 2012 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.